These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 10901292)

  • 21. Equal inhibition of HIV replication by stereoisomers of phosphatidyl-azidothymidine. Lack of stereospecificity of lysosomal phospholipase A1.
    Kumar R; Gardner MF; Richman DD; Hostetler KY
    J Biol Chem; 1992 Oct; 267(28):20288-92. PubMed ID: 1400346
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Clonal selection of HIV type 1 variants associated with resistance to foscarnet in vitro: confirmation by molecular evolutionary analysis.
    Nakano T; Morozumi H; Inuzuka S; Nagata M; Taguchi Y; Mizokami M; Okamoto T
    AIDS Res Hum Retroviruses; 1997 May; 13(7):563-73. PubMed ID: 9135874
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Long-term foscarnet therapy remodels thymidine analogue mutations and alters resistance to zidovudine and lamivudine in HIV-1.
    Mathiesen S; Dam E; Roge B; Joergensen LB; Laursen AL; Gerstoft J; Clavel F
    Antivir Ther; 2007; 12(3):335-43. PubMed ID: 17591023
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Inhibition of human immunodeficiency virus type 1 replication by phosphonoformate- and phosphonoacetate-2',3'-dideoxy-3'-thiacytidine conjugates.
    Charvet AS; Camplo M; Faury P; Graciet JC; Mourier N; Chermann JC; Kraus JL
    J Med Chem; 1994 Jul; 37(14):2216-23. PubMed ID: 8035429
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Synergistic combinations and peptides in the inhibition of human immunodeficiency virus.
    Cox S; Koshida R; Harmenberg J; Wahren B
    Adv Enzyme Regul; 1991; 31():85-97. PubMed ID: 1715118
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Synthesis and in vitro evaluation of S-acyl-3-thiopropyl prodrugs of Foscarnet.
    Gagnard V; Leydet A; Morère A; Montero JL; Lefèbvre I; Gosselin G; Pannecouque C; De Clercq E
    Bioorg Med Chem; 2004 Mar; 12(6):1393-402. PubMed ID: 15018912
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Evaluation of synergy between carbovir and 3'-azido-2',3'-deoxythymidine for inhibition of human immunodeficiency virus type 1.
    Smith MS; Kessler JA; Rankin CD; Pagano JS; Kurtzberg J; Carter SG
    Antimicrob Agents Chemother; 1993 Jan; 37(1):144-7. PubMed ID: 8431013
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Antiviral activity of phosphonoformate on rotavirus transcription and replication.
    Ríos M; Muñoz M; Spencer E
    Antiviral Res; 1995 May; 27(1-2):71-83. PubMed ID: 7486960
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Synergistic inhibition of human immunodeficiency virus isolates (including 3'-azido-3'-deoxythymidine-resistant isolates) by foscarnet in combination with 2',3'-dideoxyinosine or 2',3'-dideoxycytidine.
    Palmer S; Harmenberg J; Cox S
    Antimicrob Agents Chemother; 1996 May; 40(5):1285-8. PubMed ID: 8723486
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Impaired fitness of foscarnet-resistant strains of human immunodeficiency virus type 1.
    Tachedjian G; Mellors JW; Bazmi H; Mills J
    AIDS Res Hum Retroviruses; 1998 Aug; 14(12):1059-64. PubMed ID: 9718121
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Antiviral activity of a phosphorothioate oligonucleotide complementary to human cytomegalovirus RNA when used in combination with antiviral nucleoside analogs.
    Azad RF; Brown-Driver V; Buckheit RW; Anderson KP
    Antiviral Res; 1995 Oct; 28(2):101-11. PubMed ID: 8585764
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Synergistic inhibition of human immunodeficiency virus type 1 replication by 5-ethyl-1-ethoxymethyl-6-(phenylthio)uracil (E-EPU) and azidothymidine in vitro.
    Baba M; Ito M; Shigeta S; Tanaka H; Miyasaka T; Ubasawa M; Umezu K; Walker RT; De Clercq E
    Antimicrob Agents Chemother; 1991 Jul; 35(7):1430-3. PubMed ID: 1929304
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Inhibition of HIV-1 replication in H9 cells by nystatin-A compared with other antiviral agents.
    Selvam MP; Blay RA; Geyer S; Buck SM; Pollock L; Mayner RE; Epstein JS
    AIDS Res Hum Retroviruses; 1993 May; 9(5):475-81. PubMed ID: 7686387
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Modified tetrazolium-based colorimetric method for determining the activities of anti-HIV compounds.
    Ayisi NK; Gupta SV; Qualtiere LF
    J Virol Methods; 1991 Aug; 33(3):335-44. PubMed ID: 1664434
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The effect of combinations of ampligen and zidovudine or dideoxyinosine against human immunodeficiency viruses in vitro.
    O'Marro SD; Armstrong JA; Asuncion C; Gueverra L; Ho M
    Antiviral Res; 1992 Feb; 17(2):169-77. PubMed ID: 1554239
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Synthesis and antiviral activity of new carbonylphosphonate 2',3'-dideoxy-3'-thiacytidine conjugates.
    Charvet AS; Turin F; Faury P; Hantz O; Camplo M; Mourier N; Berthillon P; Graciet JC; Chermann JC; Trépo C
    Antiviral Res; 1994 Oct; 25(2):161-8. PubMed ID: 7847877
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Inhibition of human immunodeficiency virus in vitro by combinations of 3'-azido-3'-deoxythymidine and foscarnet.
    Koshida R; Vrang L; Gilljam G; Harmenberg J; Oberg B; Wahren B
    Antimicrob Agents Chemother; 1989 May; 33(5):778-80. PubMed ID: 2526616
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Synergistic inhibition of replication of human immunodeficiency virus type 1, including that of a zidovudine-resistant isolate, by zidovudine and 2',3'-dideoxycytidine in vitro.
    Eron JJ; Johnson VA; Merrill DP; Chou TC; Hirsch MS
    Antimicrob Agents Chemother; 1992 Jul; 36(7):1559-62. PubMed ID: 1324648
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Synthesis, hydrolytic behavior, and anti-HIV activity of selected acyloxyalkyl esters of trisodium phosphonoformate (foscarnet sodium).
    Iyer RP; Boal JH; Phillips LR; Thakker DR; Egan W
    J Pharm Sci; 1994 Sep; 83(9):1269-73. PubMed ID: 7530302
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Greatly enhanced inhibition of human immunodeficiency virus type 1 replication in CEM and HT4-6C cells by 3'-deoxythymidine diphosphate dimyristoylglycerol, a lipid prodrug of 3'-deoxythymidine.
    Hostetler KY; Richman DD; Carson DA; Stuhmiller LM; van Wijk GM; van den Bosch H
    Antimicrob Agents Chemother; 1992 Sep; 36(9):2025-9. PubMed ID: 1416896
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.